Integrin-linked kinase (ILK) is a major structural adaptor protein governing signaling complex formation and cytoskeletal dynamics. Here, through the use of conditional knock-out mice, we demonstrate a requirement for ILK in oligodendrocyte differentiation and axonal myelination in vivo. In conjunction, ILK-deficient primary oligodendrocytes are defined by a failure in process extension and an inability to form myelin membrane upon axonal contact. Surprisingly, phosphorylation of the canonical downstream targets Akt and GSK3␤ is unaffected following ILK loss. Rather, the defects are due in part to actin cytoskeleton dysregulation with a correspondent increase in active RhoA levels. Morphological rescue is possible following Rho kinase inhibition in an oligodendrocyte subset. Furthermore, phenotypic severity correlates with environmental complexity; oligodendrocytes are severely malformed in vitro (a relatively simple environment), but undergo phenotypic recovery in the context of the whole animal. Together, our work demonstrates ILK as necessary for normal oligodendrocyte development, reinforces its role as a bridge between the actin cytoskeleton and cell membrane, and highlights the overarching compensatory capacity of oligodendrocytes in response to cellular milieu.
Introduction
During development, oligodendrocyte precursor cells (OPCs) differentiate into oligodendrocytes (OLs) that extend processes to contact multiple axons of CNS neurons. The process of myelination is controlled in part by cell extrinsic factors derived from the extracellular matrix (ECM). Laminin-2 (Ln-2) is an ECM component with high relevance to OL-mediated myelination of the CNS (O'Meara et al., 2011a) . Ln-2 is deposited in developing axonal tracts (Colognato et al., 2002) , providing a ligand for the ␣6␤1 integrin receptor expressed by OLs. The ␤1 integrin subunit was shown previously to regulate OL process extension in vitro (Buttery and ffrench-Constant, 1999; Relvas et al., 2001; Liang et al., 2004; Barros et al., 2009 ) and myelination in vivo (Relvas et al., 2001; Lee et al., 2006; Barros et al., 2009; Câmara et al., 2009) . In light of these findings, precisely how ␤1 integrin transduces ECM cues via signaling intermediates, and the mechanism by which this translates to cellular responses, need to be addressed.
Integrin-linked kinase (ILK), a focal adhesion protein, binds to the cytosolic C terminus of ␤1 integrin (Hannigan et al., 1996) and mediates signaling between the ECM and the cellular interior. ILK is composed of three domains, an N-terminal ankryin domain, a pleckstrin homology domain, and a putative kinase domain. ILK forms an obligate heterotrimeric complex with particularly interesting Cys-His-rich protein (PINCH) and parvin, which together lend stability to the actin cytoskeleton at focal adhesions (Brakebusch and Fässler, 2003) . This function is likely mediated through additional signaling proteins, such as paxillin and PAK-interacting exchange factor (PIX), ultimately impacting on actin modulator proteins via Rho GTPases (Rosenberger et al., 2003) .
In this study, we sought to investigate the role of ILK in OL differentiation and myelination of the CNS. By ablating ILK from cultured OPCs, we show that it is important for their molecular and morphological differentiation. Conditional ILK loss in postnatal mice results in amyelination of optic nerve axons, an effect that is compensated for at later time points. There is evidence of a bonafide kinase function for ILK (for review, see Hannigan et al., 2011) ; however, we did not observe any changes in the phosphorylation status of its canonical targets GSK3␤ and Akt in ILKdepleted OLs. Rather, we observe an increase in active RhoA levels as a result of ILK loss, a phenomenon associated with actin cytoskeletal defects. Interestingly, pharmacological manipulation of the RhoA pathway is able to rescue aberrant morphology of a distinct population of ILK-deficient OLs. Our data indicate an important role for ILK in OL development and myelination of the CNS, which, in turn, is linked to regulation of the actin cytoskeleton. Understanding OL differentiation will be important for rectifying or circumventing myelinating diseases such as multiple sclerosis, where demyelinated lesions are characterized by stalled premyelinating OLs (Chang et al., 2002) .
Materials and Methods
Transgenic and reporter mice. The mice used in this work were cared for according to Canadian Council on Animal Care guidelines. Ethical approval for experiments conducted was obtained from the University of Ottawa Animal Care Committee under protocol number OGH-119. Ilk fl/fl and Plp-CreER T mice were provided by Dr. René St-Arnaud, McGill University, Montreal, Canada (Terpstra et al., 2003) and Dr. Brian Popko, University of Chicago, Chicago, IL (Doerflinger et al., 2003) , respectively. Two mouse strains were primarily used for experiments: Ilk fl/fl ;Plp-CreER T /ϩ mice (Ilk cKO) and Ilk fl/fl ;ϩ/ϩ [wild-type (WT)] littermate controls. An injection of 0.375-0.5 mg of tamoxifen (7.5 or 10 l of a 50 mg/ml solution, respectively) was administered to postnatal day 4 (P4) pups to induce recombination. For the low-dose tamoxifen experiments, P4 mice were given a single 10 l injection from a 2 mg/ml tamoxifen solution to induce minimal recombination. Ilk cKO mice were crossed to a floxed stop tdTomato-EGFP (mT/mG) reporter line (Muzumdar et al., 2007) to generate Ilk fl/fl ;Plp-CreER T /ϩ;mT/mG (Ilk cKO;mT/mG) mice, which were bred to homozygosity for the reporter transgene. Mice of either sex were used for all experiments.
Cell culture. OL cultures and OL/dorsal root ganglion neuron (DRGN) cocultures were derived as described previously (O'Meara et al., 2011b) . For Rho kinase (ROCK) inhibition, compound Y-27632 (C 14 H 21 N 3 O) was added to each well at a final concentration of 10 M daily for 6 d. For control wells, an equal volume of water (vehicle) was added.
Immunohistochemistry. Cell culture coverslips were fixed with 100% methanol at Ϫ20°C for 10 min or 3% paraformaldehyde (PFA) at room temperature for 15 min. Coverslips were then washed with PBS, permeabilized with 0.1% Triton X-100 solution, blocked with 10% goat serum (GS), and incubated with primary antibodies against myelin-associated glycoprotein (MAG; EMD Millipore), myelin basic protein (MBP; AbD Serotec), CC1 (Abcam), green fluorescent protein (GFP; Invitrogen), neurofilament-200 (NF-200; Sigma-Aldrich), cleaved caspase 3 (Asp175; Cell Signaling Technology), 5-bromo-2Ј-deoxyuridine (BrdU; BD Biosciences), and NG2 (EMD Millipore) in blocking solution at 4°C overnight. Coverslips were then washed with PBS and incubated with Alexa Fluor-conjugated secondary antibodies (Alexa-488, Alexa-555, Alexa-647; Invitrogen) and/or rhodamine phalloidin (Invitrogen). Samples were then counterstained with 4Ј,6-diamidino-2-phenylindole (DAPI) and mounted in Dako mounting medium.
For immunohistochemistry of murine tissue, mice were anesthetized with tribromoethanol (Avertin) and perfused transcardially with 4% PFA. Optic nerves were dissected in PBS and postfixed overnight in 4% PFA at 4°C followed by overnight cryopreservation in 30% sucrose/PBS at 4°C and then embedded in a 1:1 mixture of 30% sucrose/OCT (Sakura). Briefly, 10 m sections were washed with PBS followed by a 10 -30 min incubation in citrate buffer (10 mM citric acid, 26 mM NaOH, pH 6) for certain antibodies. Sections were blocked in either 10% GS with 1% BSA and 0.2% Triton X-100 or TBLS (0.5 mM Tris-HCl pH 7.4, 0.0085% NaCl, 0.01% BSA, 0.009% L-lysine, and 10% sodium azide) with 20% GS and 0.3% Triton X-100 for 1 h. Primary antibodies were diluted in either 1% GS with 1% BSA and 0.2% Triton X-100 or TBLS with 20% GS and 0.3% Triton X-100 and placed on sections overnight at 4°C. Sections were then washed and incubated with Alexa Fluor conjugated secondary antibodies (Invitrogen) in the same solution as primary antibodies. Sections were counterstained with DAPI and mounted in Dako mounting medium.
BrdU labeling. DIV2 OL cultures were pulsed with ϳ20 nM of BrdU for 4 h and subsequently fixed with 3% PFA at room temperature for 15 min. Coverslips were washed in PBS, permeabilized with 0.1% Triton X-100 solution, and treated with 2N HCl for 20 min on a rotary shaker. Samples were then topped up with an equal volume of 0.1 M Tris-HCl, pH 9.5, and incubated on the rotary shaker for an additional 20 min. Samples were then stained with anti-BrdU antibody using the same method as described above.
Whole-mount immunohistochemistry. Mice were anesthetized with Avertin and killed at either P14 or P28. The optic nerve was immediately removed and placed in a 4% PFA solution for 1 h at room temperature with gentle agitation. The nerve was then washed in PBS followed by a 30 min incubation in 2% Triton X-100 and blocked in a 4% BSA, 1% Triton X-100 solution. The optic nerve was then incubated overnight with an antibody against GFP in blocking solution. The next day, an Alexa Fluorconjugated secondary antibody was applied in blocking solution for 4 h, followed by washes in PBS. The optic nerves were finally counterstained with DAPI, given final washes in 0.1% Triton X-100, and mounted in Dako mounting medium. Images were acquired and processed as Z stacks through the whole-mount preparation to visualize OLs and associated internodes in their entirety.
Electron microscopy. Mice were anesthetized with Avertin and perfused transcardially with Karnovsky's fixative (4% PFA, 5% glutaraldehyde, 0.08 M sodium cacodylate, pH 7.4). The optic nerve was then removed and postfixed in Karnovsky's fixative at 4°C. Fixed optic nerves were cut into ultrathin sections, stained with uranyl acetate and lead citrate, and analyzed by electron microscopy. Axon and myelin diameters were determined using the "analysis" tool in ImageJ set to a known scale. Number of myelinated fibers relative to total fibers was then determined and subdivided into groups by axon diameter. The G ratio was calculated by dividing the axon diameter by the axon plus myelin diameter.
Western blot. Mixed glial cultures were cooled on ice for 3 min and washed with ice-cold PBS. Cells were scraped off the dishes into protein lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40) containing protease inhibitor cocktail (0.01 mg/ml pepstatin, 0.01 mg/ml aprotinin, 0.01 mg/ml leupeptin, 5 mM Na 3 VO 4 , 1 mM PMSF) and centrifuged at high speed to remove insoluble material. For optic nerves, protein was extracted through tissue homogenization in a lysis buffer solution (50 mM Tris pH 7.4, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, and 1% Triton X-100) containing protease inhibitor cocktail plus 50 mM NaF. Optic nerves from three mice were pooled for each protein sample. For Western blotting of proteins obtained from OL cultures, vessels were briefly cooled on ice before cells were lysed in a commercial lysis buffer (Cytoskeleton). Lysate was then centrifuged at high speed to remove insoluble material. Western blot exposure films were scanned with EPSON Perfection 2450 PHOTO scanner, and images were imported into ImageJ. A box of standard dimensions was placed over each band of a given blot, and the mean gray value was measured for each band. Levels of a given protein of interest were normalized to the GAPDH band intensity.
His-TAT (trans-activator of transcription)-NLS (nuclear localization sequence)-Cre (TAT-
Cre) treatment. TAT-Cre (Excellgen) was added to mixed glial cultures at a concentration of ϳ2-5 M for 1-4 h. The following day, the efficiency of the recombination was qualitatively assessed by EGFP fluorescence. OPCs were extracted from the mixed glial cultures and seeded onto Ln-2 substrate 72 h after TATCre administration as described previously (O'Meara et al., 2011b) .
Small G-protein ELISA (G-LISA) RhoA activation assay. DIV3 vehicle and TAT-Cretreated primary OLs were scraped into RhoA G-LISA lysis buffer, and clarified lysates were flash frozen in liquid nitrogen. The G-LISA assay was conducted on the lysates according to the manufacturer's instructions (Cytoskeleton). Raw luminescence values were normalized to total RhoA levels as measured by Western blotting.
Statistical analysis. All statistical analyses were performed using Prism 5/6 GraphPad software. Unless stated otherwise, two-tailed Student's t tests were used for statistical analyses, with significance set at p Ͻ 0.05.
Results

ILK is required for primary OL differentiation
ILK is well known for its role in focal adhesion stabilization (Legate et al., 2006) , a function highly dependent on its binding partner ␣-parvin. Through ␣-parvin, ILK is connected to the actin cytoskeleton, thus linking cellular interior and ECM. Both ILK and ␣-parvin proteins were detected at all differentiation time points in cultured primary murine OLs (Fig. 1A) . Expression of 2Ј,3Ј-cyclicnucleotide 3Ј-phosphodiesterase (CNP) and MBP indicates the degree of OL differentiation in the cultures, as these are intermediate and late markers of OL differentiation, respectively ( 1D). Administration of TAT-Cre also significantly reduced ILK protein levels, and that of its obligate partner ␣-parvin in transgenic mixed glial cultures ( Fig.  1 E, F ). OPCs were then derived from these TAT-Cre-treated mixed glial cultures as described previously (O'Meara et al., 2011b) and seeded on Ln-2 substrates as a purified population for further study.
OPC differentiation requires both molecular and morphological cellular alterations. Molecular differentiation coincides with decreased expression of NG2 concomitant with MAG and MBP expression. Upon loss of ILK (Ilk Ϫ/Ϫ ), a significant proportion of OPCs persisted as NG2 ϩve precursors at DIV3 and DIV6 of the differentiation time course (Fig. 2 A, B) ϩve precursors was not a completely penetrant phenotype in response to ILK loss. Furthermore, MBP protein levels (as measured by Western blot) were decreased in TAT-Cre-treated cultures at both DIV3 and 6 (Fig. 2C) .
To investigate whether this apparent delay in lineage progression was an artifact of differential expansion/collapse of Ilk Ϫ / Ϫ or Ilk fl/fl OL populations, we conducted a series of cell death and proliferation assays. When total numbers of Ilk Ϫ / Ϫ and Ilk fl/fl OL-lineage cells were respectively considered as 100% at DIV1, there was no subsequent difference in cell counts between the genotypes at either DIV3 or DIV6 (Fig. 3A) . This suggests that loss of ILK does not translate to compromised survival of OL-lineage cells. In addition, there was no significant difference in the percentage of cleaved caspase 3 ϩve OL-lineage cells at DIV1, DIV3, or DIV6 (Fig. 3B ). When this same cleaved caspase 3 data was parsed to segregate mature and immature OL-lineage cells, we still did not observe any significant difference in cleaved caspase 3 activity between Ilk Ϫ/Ϫ and Ilk fl/fl populations (Fig. 3C) . Finally, we investigated whether there were differences in the rate of proliferation between Ilk Ϫ/Ϫ and Ilk fl/fl OPCs. We did not observe any difference in BrdU incorporation after a 4 h pulse at DIV2 (Fig.  3D) . Thus, our data strongly suggest a role for ILK in the initiation of a molecular differentiation program triggering MAG and MBP expression. Simply stated, upon loss of ILK, OPCs tend to persist as NG2 ϩve precursors throughout the 6 d differentiation time course.
Loss of ILK inhibits morphological maturation of OLs in primary culture
OL morphological differentiation is characterized by extension of multiple processes by OPCs, eventually generating myelin-like membranous structures. This morphological maturation coincides with the expression of MAG. At DIV3 of differentiation, MAG ϩve Ilk fl/fl OLs had developed a complex arbor network, and at DIV6, these OLs had further differentiated to form myelin-like membranes (Fig. 4A, top) . Interestingly, most MAG ϩve Ilk Ϫ/Ϫ OLs did not produce either an arbor network or myelin-like membranes (Fig. 4A,   bottom ). Rather, they only extended a few primary arbors. To quantify this observation, a staging scheme was developed, from Stage 1 to Stage 4, where cells were binned based on their increasing morphological complexity (Fig. 4B) (Fig. 4D,E) . The observed morphological deficits resulting from ILK loss were not a consequence of EGFP induction, as Cre-recombined Ilk ϩ/ϩ ;mT/mG OLs displayed normal morphology (data not shown).
Loss of ILK impacts in vitro myelinating capacity of OLs
Due to the morphological deficits observed when Ilk Ϫ/Ϫ OLs are cultured on Ln-2, we hypothesized that this would translate to compromised myelinating capacity in an in vitro myelination paradigm. To this end, we used DRGNs in coculture with primary OLs as described previously (O'Meara et al., 2011b) . At DIV3 of coculture, there was no significant difference in the capacity for Ilk Ϫ/Ϫ OLs to contact and enwrap DRGN neurites compared to Ilk fl/fl OLs (Fig. 5A-C) . However, at DIV6, Ilk
OLs contacted fewer DRGN neurites and had a reduced capacity to enwrap neighboring neurites with MBP ϩve membrane (Fig.  5A-C) . The driving force underlying these deficits appeared to be an impaired ability of Ilk Ϫ/Ϫ OLs to form myelin leaflets (Fig.  5D ). These structures were observed solely when OLs were cocultured with neurons, and may represent an in vitro version of early myelin sheaths. Ilk Ϫ/Ϫ OLs produced significantly fewer myelin leaflets per cell than Ilk fl/fl OLs (Fig. 5E ). These defects were not a result of ectopic EGFP expression, as Ilk ϩ/ϩ ;mT/mG OLs myelinated DRGN neurites normally, and produced expected numbers of myelin leaflets (data not shown). In addition, we confirmed that there were no differences in the density of DRGN neurite bed underlying myelinating OLs (data not shown), suggesting the OLs themselves were solely responsible for the myelination phenotypes in response to ILK loss.
Generation of ILK conditional knock-out mice for in vivo study
To study the role of ILK in CNS myelination in vivo and avoid embryonic lethality associated with ILK deletion, we used the Cre-loxP system. Ilk fl/fl mice were crossed to Plp-CreER T mice to generate Ilk fl/fl ;Plp-CreER T conditional knock-out mice (hereafter referred to as Ilk cKO mice). The Plp-CreER T line of mice allows for spatial and temporal control of floxed Ilk recombination; the Cre gene is placed under the control of the proteolipid protein (Plp) promoter, allowing for OL-specific expression (Doerflinger et al., 2003) . As well, the Cre protein is fused to a mutated estrogen receptor, requiring tamoxifen administration for nuclear translocation (Fig. 6A) .
The optic nerve was chosen as a model system to study the impact of Ilk gene deletion on myelination, as it offers a relatively homogeneous population of cell types, with a large percentage of OLs, compared to other CNS tissues. Since myelination of the optic nerve is initiated ϳ6 d postnatally (Thomson et al., 2005) , Ilk cKO mice and WT littermates were administered tamoxifen at P4. Western blot analysis revealed a decrease in total ILK protein levels in the optic nerves of these mice following tamoxifen injection (Fig. 6B) . To verify specificity of the promoter to the OL lineage, Ilk cKO mice were crossed to the mT/mG reporter line (generating Ilk cKO;mT/mG mice). In these mice, EGFP is expressed predominantly in cells positive for the myelin markers MBP and MAG (Fig. 6C) , demonstrating the specificity of the Plp promoter to OLs.
Transient amyelination following ILK ablation in vivo
Initial analysis of IIk cKO mice revealed no overt signs of shaking, ataxia, tremor, or head wobbling following tamoxifen injection at P4. Mice were killed at two developmental time points, P14 and P28, for ultrastructural analysis by electron microscopy. The optic nerves of P14 Ilk cKO mice displayed a significant reduction in total number of myelinated small caliber axons (0.3-0.8 m) relative to WT littermate controls (Fig. 6 D, E) . In contrast, there was no significant difference in number of myelinated large caliber axons (0.8 m and above) at this time point (Fig. 6 D, E) . That small rather than large caliber axons are affected is in concordance with previous work done on OL-specific knock-out mice for other members of the integrin-signaling pathway (Chun et al., 2003; Câmara et al., 2009; Forrest et al., 2009 ). To determine whether myelin thickness was also affected by ILK loss, we assessed the G-ratio (axon diameter/axon and myelin diameter) of axons in two separate groups; those Ͻ0.8 m and those Ն0.8 m in diameter (Fig. 6F ) . There was no significant difference in the average G-ratio of axons either Ͻ0.8 m or Ն0.8 m. As well, no difference was observed in axonal distribution (by diameter) between WT and Ilk cKO littermates (Fig. 6G) , excluding a shift in axon caliber frequency as responsible for the observed decrease in total number of myelinated small caliber axons.
Interestingly, when Ilk cKO mice were analyzed at P28, there was no observable difference in total number of myelinated fibers (at any given diameter) relative to control mice (Fig. 6H,I ). In addition, there was no significant difference in the average G-ratio of axons with diameters either Ͻ0.8 m or Ն0.8 m in P28 optic nerves (Fig. 6J) . Furthermore, no significant shift was observed between control and Ilk cKO mice in axonal distribution by diameter (Fig. 6K) , discounting the possibility of axonal loss as explanation for the resurgence of small myelinated fibers by P28. Rather, our results imply gradual myelination recovery of P14 amyelinated axonal populations in the ILK-depleted optic nerve.
The transient defects observed are due neither to a loss or a gain in total number of OLs as measured by NG2
ϩve OPCs and CC1
ϩve mature OLs at P14 or P28 (Fig. 7 A, B) . To assess the possibility of OL turnover, we measured the number of cleaved caspase 3 ϩve cells in the optic nerves of P14 Ilk cKO and WT mice. No significant increase in the number of apoptotic cells was observed in ILK-depleted optic nerves (Fig. 7C) In an effort to draw parallels between defects observed in vitro (morphological aberrations) and in vivo (loss of myelination), we used a low-dose tamoxifen regimen in our Ilk cKO;mT/mG and PLPCreER T ;mT/mG reporter control animals. Reducing tamoxifen levels allowed for spatial resolution of individual recombined OLs and associated myelin processes. Following administration of the drug, mice were killed at P14, and the optic nerves were removed for whole-mount preparations. A series of Z stack images were taken to capture recombined OLs in their entirety. Strikingly, at a strictly qualitative level, many of the ILK-depleted OLs displayed fully formed myelin internodes similar to controls (Fig. 8A) . However, the average internode length was less than that measured for reporter controls (Fig. 8 A, B) , corroborating our in vitro data for a subset of mature ILK-depleted OLs, which form smaller amounts of membrane. As well, loss in internode length implies a defect in the growth of the process responsible, as the distance it is able to travel around the axon will determine length of the myelin segment. In conjunction, we measured internode diameter to account for possible bias as a result of axon diameter (larger axons having longer myelin internodes and vice versa). No significant difference was observed between ILK-depleted and control OLs (Fig. 8B) eliminating the variable as potential confounder. We did, however, observe ILK-depleted OLs whose processes failed to form myelin internodes (Fig. 8C) . While occasionally present in controls, the defect was more prevalent in the optic nerves of Ilk cKO;mT/mG mice, suggesting a role for ILK in directing myelin formation following axonal contact and/or process extension in vivo, defects observed in both purified and cocultured OLs in vitro. Together, our data, both in vitro and in vivo, point to a role for ILK in the initial steps of myelination and suggest that the observed amyelination is not due to a loss of OLs but rather to a defect in OL branching and membrane formation.
Morphological deficits of Ilk-deficient OLs are associated with abnormal actin accumulation and are partially rescued through Rho kinase inhibition
In our search for a mechanistic explanation for the aforementioned OL defects, we first explored the phosphorylation state of ILK's canonical downstream effectors Akt and GSK3␤. To our surprise, no apparent change in Akt (Ser 473) or GSK3␤ (Ser 9) phosphorylation was observed in ILK-depleted OL cultures at DIV3 or DIV6 (Fig. 9 A, B) . We thus sought to investigate other possible mechanisms that could account for the observed morphological aberrations. ILK has previously been shown to colo- calize with ␤1 integrin and paxillin in OL focal adhesions (Chun et al., 2003) . We further demonstrate ILK localization to the filamentous-actin (F-actin)-rich leading edge or distal tips of outgrowing processes in the immortalized OL cell line OLi-neu (data not shown). When ILK is lost from primary OLs, there is an abnormal accumulation of F-actin in the cell body and subcortically in the developing process (Fig. 9C,D) . A well-known regulator of neural cell actin organization is the small RhoGTPase RhoA (Govek et al., 2005) , and perturbation of RhoA results in morphologically aberrant OLs (Rajasekharan et al., 2009 (Rajasekharan et al., , 2010 . As ILK is required for RhoA-dependent actin cytoskeleton reorganization (Graness et al., 2006), we hypothesized that the morphological deficits and actin accumulation in Ilk Ϫ/Ϫ OLs is caused by upregulation of the RhoA signaling pathway. Indeed, when we probed for active RhoA levels, an increase in GTP bound RhoA was detected in our TAT-Cretreated DIV3 OL cultures (Fig. 9E) .
Stimulation of the RhoA pathway involves activation of ROCK, an event that is associated with destabilization of actin. The ROCK inhibitor Y-27632 is often used to rectify the effects of overactive RhoA signaling. We tested whether Y-27632 treatment would improve the morphological deficits of Ilk Ϫ/Ϫ OLs. Interestingly, this did not rescue the morphological deficits of MAG ϩve Ilk Ϫ/Ϫ OLs (data not shown). Rather, Y-27632 had a specific impact on the morphology of immature (MAG Ϫve ) Ilk Ϫ/Ϫ OLs (Fig. 10A) . Under normal conditions, MAG Ϫve Ilk Ϫ/Ϫ OLs mostly displayed primary (1°) branched morphology, whereas MAG Ϫve Ilk fl/fl OLs tended to have equal numbers of 1°and secondary/tertiary (2°/3°) branched cells (Fig. 10B) . 
Discussion
ILK regulates OL development
Following ILK loss in enriched primary OL cultures, two phenotypes were observed: (1) the persistence of NG2 ϩve OPCs coupled with a decrease in mature (MAG ϩve ) cells, and (2) an inability of the MAG ϩve population to form arborizations or myelin-like membranes (Fig. 11) . At first glance, it is plausible to suspect a general delay in Ln-2 mediated differentiation as cause. While, to a degree, we believe this is true, several observations suggest this interpretation as overly simplistic. First, the persistence of NG2 ϩve precursors in the Ilk Ϫ/Ϫ population remains static from DIV3 to DIV6, implying that this OL subpopulation requires ILK signaling for both morphological and molecular differentiation. Second, there is the discord between morphology and maturation markers observed in a separate OL subpopulation, those capable of MAG expression upon ILK loss. Together, this suggests a functional OL heterogeneity exists with regard to ILK. Some cells necessitate ILK to initiate the entire differentiation gamut, whereas others require ILK for morphological maturation only. Alternatively, ILK's role could be linked to the exact maturation stage of the precursor cell at the time of its deletion. In either case, we would assume functional differences are an outcome of signaling alteration downstream of ILK, most likely through a shift in ILK complex composition at the ␤1 integrin cytoplasmic tail. Elucidation of the mechanistic switch that de- fines the observed OL subgroups will be important as we move toward a fuller understanding of OL development.
Initial characterization of P14 Ilk cKO optic nerves revealed a decrease in total number of myelinated small caliber axons. Extrapolating from our in vitro (aberrant morphological differentiation) and in vivo (low-dose tamoxifen) data, we suggest a dual explanation for the small axon phenotype, that Ilk Ϫ/Ϫ OLs suffer both from an inability to generate and extend the requisite network of processes as well as a deficiency in their capacity to initiate myelination following axonal contact. With regard to the former, OL morphological complexity is negatively correlated with the diameter of the axon(s) it myelinates. Individual OLs will either myelinate a large number of small axons or a small number of large axons (Butt and Berry, 2000; Almeida et al., 2011) . Thus, following ILK loss, we would expect exacerbation of small axon amyelination as a result of the OL's inability to generate a high number of processes. The second mechanism, failure to initiate myelination following axonal contact, was first proposed by Câmara et al. (2009) in a dominant-negative model of ␤1 integrin. The idea is as follows: once axonal contact is established, the OL process requires an axonal ligand "threshold" be broken to trigger a myelinating event. Larger axons are unaffected in this paradigm, as they provide excess surface ligand. Smaller axons, however, necessitate integrinmediated signal amplification and, as such, are preferentially affected.
In contrast to our own model, Câmara et al. (2009) initially proposed and then rejected the possibility of morphological abnormalities as a cause for small axon amyelination. We believe our in vitro data, together with the low-dose tamoxifen experiments, imply morphological defects following ILK loss in vivo. However, our two models do not preclude one from the other. Rather, they highlight possible differences in functional outcome between receptor and effector disruption. Our findings are also congruent with work published by others (Benninger et al., 2006) , which controversially concluded no essential role for ␤1 integrin in CNS myelination. Here, the authors focused primarily on G ratio as a readout for myelination, which, similar to our own model, was unaffected. As well, the study was conducted primarily in older mice (2 months and older), by which time full phenotypic recovery had occurred in our model. Coupled with our work, these findings strongly suggest that the ␤1 integrin signaling pathway is critical for myelination during a small developmental window, with compensation occurring thereafter.
As alluded to, our in vivo model demonstrates the capacity for compensation. When considering the transient nature of the amyelination phenotype, we are presented with two general possibilities, that death of Ilk Ϫ/Ϫ OLs permits WT cells to compensate or that Ilk Ϫ/Ϫ OLs are developmentally delayed, requiring more time for myelination to proceed. We have eliminated the former, as there was no change in total OL number or an increase in apoptosis between the optic nerves of Ilk cKO and WT mice. The second scenario, a delay in morphological maturation, therefore seems the most likely explanation, that upon ILK loss, compensation occurs through upregulation of other integrin adhesion complexes such as those containing Fyn or focal adhesion kinase. Alternatively, compensation could arise through a switch in Ln-2 directed signaling from integrin to dystroglycan, another Ln-2 receptor expressed by OLs (Colognato et al., 2007). cell population must occur through pathways independent of Rho/ROCK signaling. One possibility is deactivation of the ILK-regulated neural Wiskott-Aldrich syndrome protein (N-WASP)/Arp2/3 complex (mediators of actin polymerization), as N-WASP disruption negatively impacts OL process outgrowth (Bacon et al., 2007) . In addition, ILK is required for ␣-parvin/␤-parvin stabilization and paxillin localization, both of which bind F-actin directly (Attwell et al., 2003; Legate et al., 2006) . Therefore, loss of ILK could lead to F-actin/integrin/ECM uncoupling, which may explain the observed OL morphological defects. Additionally, Ilk Ϫ/Ϫ OLs are characterized by an inability to extend myelin-like membranes. While this is possibly due to cytoskeletal defects, our results following ROCK inhibition (improved branching but not membrane formation) suggest other pathways are at play, implying that ILK's governance of OL process outgrowth and myelin membrane formation occur through separate mechanisms.
Through our work, we have begun to dissect ILK-directed signaling pathways overseeing unique aspects of OL development. Precisely which downstream targets potentiate ILK's role in cytoskeletal reorganization and how their actions differ at varying stages of OL differentiation remain intriguing questions for the future. ϩve cells that remain in a precursor state, and a second, larger group that progresses through the various stages of morphological maturation with concomitant expression of molecular markers of differentiation (MAG). B, Following ILK loss, an increased percentage of OPCs fail to commit to the maturing population, remaining as NG2 ϩve precursors. Simultaneously, a second pool of ILK-depleted OLs express MAG, but remain morphologically stunted. This pool correlates with defects observed in vivo. C, ROCK inhibition rescues a select group of immature OLs, restoring secondary and tertiary branching to normal levels. However, cells expressing MAG do not display a similar increase in morphological maturity, suggesting differential regulation of the Rho/ROCK pathway by ILK between varying OL subgroups.
